Millennium Management’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Millennium Management’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,500	Closed	-$125K	–	7395
2022 Q3	$125K	Sell	12,500 -2,564	-17%	-$25.5K	﹤0.01%	5886
2022 Q2	$149K	Hold	15,064	–	–	﹤0.01%	5775
2022 Q1	$148K	Sell	15,064 -28,235	-65%	-$277K	﹤0.01%	5977
2021 Q4	$422K	Sell	43,299 -6,048	-12%	-$59.2K	﹤0.01%	5224
2021 Q3	$483K	Buy	49,347 +12,500	+34%	+$121K	﹤0.01%	5384
2021 Q2	$357K	Buy	+36,847	New	+$359K	﹤0.01%	5608

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management's PKBO Position: Q4 2022 in Review

Millennium Management sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 12,500 shares — an estimated $125K sold.

Millennium Management first reported a position in PKBO in Q2 2021 and held it in 6 quarters. The position peaked at $483K in Q3 2021. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Millennium Management reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 12,500 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $125K.
Millennium Management first reported a position in Peak Bio, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Millennium Management's Peak Bio, Inc. Common Stock position peaked at $483K in Q3 2021.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.